Cargando…
Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial
OBJECTIVE: To examine the long-term effects of early low-dose prednisolone use in patients with rheumatoid arthritis (RA) on cardiovascular (CV) morbidity and mortality. DESIGN: Retrieval of data from a 2-year open randomised trial comparing prednisolone 7.5 mg/day in addition to disease-modifying a...
Autores principales: | Ajeganova, Sofia, Svensson, Björn, Hafström, Ingiäld |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987742/ https://www.ncbi.nlm.nih.gov/pubmed/24710131 http://dx.doi.org/10.1136/bmjopen-2013-004259 |
Ejemplares similares
-
Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
por: Hafström, Ingiäld, et al.
Publicado: (2014) -
Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria
por: Svensson, Björn, et al.
Publicado: (2013) -
Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study
por: Engvall, Inga-Lill, et al.
Publicado: (2008) -
Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort
por: Hafström, Ingiäld, et al.
Publicado: (2019) -
Erosion-free rheumatoid arthritis: clinical and conceptional implications—a BARFOT study
por: Svensson, Björn, et al.
Publicado: (2022)